Dr. Martin S. Weber

 
Staff Status
unigoe
 

1-30 of 30
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2023 Journal Article | Overview
    ​ ​Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A Review​
    Dybowski, S.; Torke, S. & Weber, M. S. ​ (2023) 
    JAMA Neurology,.​ DOI: https://doi.org/10.1001/jamaneurol.2022.5332 
    Details  DOI  PMID  PMC 
  • 2022 Journal Article | 
    ​ ​Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?​
    Geladaris, A.; Torke, S. & Weber, M. S. ​ (2022) 
    CNS Drugs36(10) pp. 1019​-1030​.​ DOI: https://doi.org/10.1007/s40263-022-00951-z 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic​
    Weber, M. S. ; Nicholas, J. A. & Yeaman, M. R.​ (2021) 
    Neurology - Neuroimmunology Neuroinflammation8(6) pp. e1067​.​ DOI: https://doi.org/10.1212/NXI.0000000000001067 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Targeting B cells in multiple sclerosis​
    Sellebjerg, F. & Weber, M. S. ​ (2021) 
    Current Opinion in Neurology34(3) pp. 295​-302​.​ DOI: https://doi.org/10.1097/WCO.0000000000000938 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders​
    Traub, J.; Husseini, L. & Weber, M. S. ​ (2021) 
    Pharmaceuticals14(1) pp. 37​.​ DOI: https://doi.org/10.3390/ph14010037 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod​
    Maass, F. ; von Gottberg, P.; Franz, J.; Stadelmann, C. ; Bähr, M.   & Weber, M. S. ​ (2021) 
    Frontiers in Neurology12.​ DOI: https://doi.org/10.3389/fneur.2021.561158 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​Concurrent axon and myelin destruction differentiates X‐linked adrenoleukodystrophy from multiple sclerosis​
    Bergner, C. G.; Genc, N.; Hametner, S.; Franz, J.; Mitkovski, M.; Weber, M. S.   & Stoltenburg‐Didinger, G. et al.​ (2021) 
    Glia69(10) art. glia.24042​.​ DOI: https://doi.org/10.1002/glia.24042 
    Details  DOI  PMID  PMC 
  • 2021 Journal Article | Research Paper
    ​ ​Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus​
    Fernandez Garcia-Agudo, L.; Steixner-Kumar, A. A.; Curto, Y.; Barnkothe, N.; Hassouna, I. ; Jähne, S.   & Butt, U. J. et al.​ (2021) 
    Cell Reports36(8) art. S2211124721009827​.​ DOI: https://doi.org/10.1016/j.celrep.2021.109548 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article
    ​ ​Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS​
    Häusler, D.; Hajiyeva, Z.; Traub, J. W.; Zamvil, S. S.; Lalive, P. H.; Brück, W.   & Weber, M. S. ​ (2020) 
    Neurology - Neuroimmunology Neuroinflammation7(3) pp. e698​.​ DOI: https://doi.org/10.1212/NXI.0000000000000698 
    Details  DOI 
  • 2020 Journal Article | Editorial Contribution (Editorial, Introduction, Epilogue)
    ​ ​Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients​
    Rommer, P. S.; Weber, M. S. ; Illes, Z. & Zettl, U. K.​ (2020) 
    Frontiers in Immunology11.​ DOI: https://doi.org/10.3389/fimmu.2020.00137 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Anti-CD20 therapies and pregnancy in neuroimmunologic disorders​
    Kümpfel, T.; Thiel, S.; Meinl, I.; Ciplea, A. I.; Bayas, A.; Hoffmann, F. & Hofstadt-van Oy, U. et al.​ (2020) 
    Neurology - Neuroimmunology Neuroinflammation8(1) pp. e913​.​ DOI: https://doi.org/10.1212/NXI.0000000000000913 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis​
    Torke, S. & Weber, M. S. ​ (2020) 
    Expert Opinion on Investigational Drugs29(10) pp. 1143​-1150​.​ DOI: https://doi.org/10.1080/13543784.2020.1807934 
    Details  DOI 
  • 2020 Journal Article
    ​ ​B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis​
    Nissimov, N.; Hajiyeva, Z.; Torke, S.; Grondey, K.; Brück, W. ; Häusser-Kinzel, S. & Weber, M. S. ​ (2020) 
    Proceedings of the National Academy of Sciences117(41) pp. 25690​-25699​.​ DOI: https://doi.org/10.1073/pnas.2012249117 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders​
    Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al.​ (2020) 
    Neurology94(4) pp. e407​-e418​.​ DOI: https://doi.org/10.1212/WNL.0000000000008684 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients​
    Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al.​ (2020) 
    Journal of Neuroinflammation17(1).​ DOI: https://doi.org/10.1186/s12974-020-01824-2 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients​
    Traub, J.; Häusser-Kinzel, S. & Weber, M. ​ (2020) 
    International Journal of Molecular Sciences21(14) pp. 5021​.​ DOI: https://doi.org/10.3390/ijms21145021 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease​
    Häusler, D.; Torke, S. & Weber, M. S. ​ (2020) 
    Frontiers in Immunology11.​ DOI: https://doi.org/10.3389/fimmu.2020.00301 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease​
    Torke, S.; Pretzsch, R.; Häusler, D.; Haselmayer, P.; Grenningloh, R.; Boschert, U. & Brück, W.  et al.​ (2020) 
    Acta Neuropathologica140(4) pp. 535​-548​.​ DOI: https://doi.org/10.1007/s00401-020-02204-z 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​CCL11 Differentially Affects Post-Stroke Brain Injury and Neuroregeneration in Mice Depending on Age​
    Lieschke, S.; Zechmeister, B.; Haupt, M.; Zheng, X.; Jin, F.; Hein, K. & Weber, M. S.  et al.​ (2020) 
    Cells9(1) pp. 66​.​ DOI: https://doi.org/10.3390/cells9010066 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany​
    Bittner, S.; Engel, S.; Lange, C.; Weber, M. S. ; Haghikia, A.; Luessi, F. & Korn, T. et al.​ (2019) 
    Der Nervenarzt90(12) pp. 1245-1253​-1253​.​ DOI: https://doi.org/10.1007/s00115-019-0760-0 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ ​Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion​
    Garcia-Agudo, L. F.; Janova, H.; Sendler, L. E.; Arinrad, S.; Steixner, A. A.; Hassouna, I. & Balmuth, E. et al.​ (2019) 
    The FASEB Journal33(7) pp. 8634​-8647​.​ DOI: https://doi.org/10.1096/fj.201900337R 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Reply: Neither human nor mouse is hypercalcaemic with 250 nmol/l 25-hydroxyvitamin D​
    Häusler, D.; Torke, S.; Peelen, E.; Bertsch, T.; Weber, M.; Heilmann, M. & Djukic, M.  et al.​ (2019) 
    Brain: A Journal of Neurology143(2) pp. e10​-e10​.​ DOI: https://doi.org/10.1093/brain/awz389 
    Details  DOI 
  • 2019 Journal Article
    ​ ​056 Efficacy and safety of the Bruton’s tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study​
    Montalban, X.; Arnold, D. L; Weber, M. S ; Staikov, I.; Piasecka-Stryczynska, K.; Gillett, A. & Martin, E. C et al.​ (2019) 
    Journal of Neurology, Neurosurgery & Psychiatry90(e7) pp. A18.2​-A19​.​ DOI: https://doi.org/10.1136/jnnp-2019-anzan.49 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis​
    Greenfield, A. L.; Dandekar, R.; Ramesh, A.; Eggers, E. L.; Wu, H.; Laurent, S. & Harkin, W. et al.​ (2019) 
    JCI Insight,.​ DOI: https://doi.org/10.1172/jci.insight.126599 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Defining distinct features of anti-MOG antibody associated central nervous system demyelination​
    Weber, M. S. ; Derfuss, T.; Metz, I.   & Brück, W. ​ (2018) 
    Therapeutic Advances in Neurological Disorders11 pp. 175628641876208​.​ DOI: https://doi.org/10.1177/1756286418762083 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Aktuelles aus der Forschung​
    Faissner, S. & Weber, M. ​ (2018) 
    Aktuelle Neurologie45(09) pp. 690​-691​.​ DOI: https://doi.org/10.1055/a-0664-6010 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Aktuelles aus der Forschung​
    Faissner, S. & Weber, M. ​ (2017) 
    Aktuelle Neurologie44(07) pp. 510​-512​.​ DOI: https://doi.org/10.1055/s-0043-110327 
    Details  DOI 
  • 2016 Journal Article
    ​ ​CD14 is a key organizer of microglial responses to CNS infection and injury​
    Janova, H. ; Böttcher, C.; Holtman, I. R.; Regen, T. ; Rossum, D. van ; Götz, A.   & Ernst, A.-S.  et al.​ (2016) 
    Glia64(4) pp. 635​-649​.​ DOI: https://doi.org/10.1002/glia.22955 
    Details  DOI  PMID  PMC 
  • 2016 Journal Article
    ​ ​Monitoring of blood parameters under course-modified MS therapy. Substance-specific relevance and current recommendations for action​
    Klotz, L.; Berthele, A.; Brück, W. ; Chan, A.; Flachenecker, P.; Gold, R. & Haghikia, A. et al.​ (2016) 
    Der Nervenarzt87(6) pp. 645​-659​.​ DOI: https://doi.org/10.1007/s00115-016-0077-1 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article
    ​ ​Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases​
    Kowarik, M. C.; Grummel, V.; Wemlinger, S.; Buck, D.; Weber, M. S. ; Berthele, A. & Hemmer, B.​ (2014) 
    Journal of Neurology261(1) pp. 130​-143​.​ DOI: https://doi.org/10.1007/s00415-013-7145-2 
    Details  DOI  PMID  PMC  WoS 

Publication List

Type

Subtype

Date issued

Author

Project

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp00783
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.